期刊文献+

术后中性粒细胞/淋巴细胞比值变化对肝细胞肝癌切除术后患者预后的影响 被引量:2

Postoperative neutrophil to lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after curative hepatectomy
下载PDF
导出
摘要 目的探讨术后外周血中性粒细胞/淋巴细胞比值(NLR)变化在预测肝细胞肝癌切除术后患者预后的价值。方法回顾性分析2007年1月至2009年12月在中山大学孙逸仙纪念医院肝胆外科根治性肝癌切除术155例患者的临床资料。根据患者术前1周内及术后1月外周血血常规结果计算NLR变化,将患者分为NLR升高组和NLR降低组。应用Kaplan-Meier方法分析生存曲线,Cox回归模型评估影响总体生存率的预后因素。结果 NLR降低组(108例)和NLR升高组(47例)的1、3、5年总体生存率分别为91.2%、80.4%、49.5%和80.2%、71.6%、42.5%(P<0.05)。肿瘤复发时间(TTR)中位数:NLR降低组为19.9月,升高组为15.2月(P<0.05)。Cox多因素分析显示术后NLR变化、肿瘤大小、肿瘤分期是影响总体生存率的独立预后因素。结论术后NLR变化是影响肝细胞肝癌切除术后患者预后的独立危险因素,术后NLR升高的患者预后差。 Objective To investigate the postoperative neutrophil to lymphocyte ratio (NLR) change in predicting the prognosis of patients after radical resection of hepatocellular carcinoma. Methods Clinical data of 155 patients with hepatocellular carcinoma (HCC) who underwent radical hepatectomy in Depart ment of Hepatobiliary Surgery, the Sun Yat-sen Memorial Hospital from January 2007 to December 2009 were analyzed retrospectively. NLR changes were calculated based on the routine examination results of peripheral blood within one week before and one month after surgery. Patients were divided into the NLR decreased group and the NLR increased group according to NLR change. Kaplan-Meier method was used to analyze survival curve and ~ox proportional hazard model was used to evaluate theprognostic factors of overall survival. Results The 5-year overall survival rates were 91.2%, 80.4%, 49.5% in NLR decreased group (108 cases) and 80.2%, 71.6%, 42.5% in NLR increased group (47 cases) (P〈0.05). The median time to recurrence (TYR) was 19.9 months in NLR decreased group, and 15.2 months in NLR increased group(P〈0.05). Cox multivariate analysis showed NLR change, tumor size, tumor stage were independent prognostic factors of overall survival. Conclusion The postoperative NLR change was an independent prognostic factor for HCC patient underwent radical hepatectomy, and patients with increased NLR indicated poor survival.
出处 《岭南现代临床外科》 2014年第5期509-512,共4页 Lingnan Modern Clinics in Surgery
基金 广东省医学科学技术基金(编号:B2012101)
关键词 中性粒细胞/淋巴细胞比值 肝细胞肝癌 预后 Neutrophil to lymphocyte ratio Hepatocellular carcinoma Prognosis
  • 相关文献

参考文献13

  • 1Bruix J,Sherman M.Practice Guidelines Committee,American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma[J].Hepatology,2005,42(5):1208-1236.
  • 2Joyce JA,Pollard JW.Microenvironmental regulation of metastasis[J].Nat Rev Cancer,2009,9(4):239-252.
  • 3Guthrie GJ,Charles KA,Roxburgh CS,et al.The systemic inflammation-based neutrophil-lymphocyte ratio:experience in patients with cancer[J].Crit Rev Oncol Hematol,2013,88 (1):218-230.
  • 4Grivennikov SI,Greten FR,Karin M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899.
  • 5Oh BS,Jang JW,Kwon JH,et al.Prognostic value of Creactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma[J].BMC Cancer,2013,13:78.
  • 6Ding PR,An X,Zhang RX,et al.Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer[J].Int J Colorectal Dis,2010,25(12):1427-1433.
  • 7马晋平,王智,林建伟,吴恺明,陈剑辉,陈创奇,蔡世荣,何裕隆,詹文华.中性粒细胞/淋巴细胞比值在胃癌预后评估中的应用[J].中华胃肠外科杂志,2011,14(12):944-947. 被引量:34
  • 8Yao Y,Yuan D,Liu H,et al.Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy[J].Cancer Immunol Immunother,2013,62(3):471-479.
  • 9Azab B,Bhatt VR,Phookan J,et al.Usefulness of the neutrophil-to-lymphocyte ratio inpredicting short-and long-term mortality in breast cancer patientsq[J].Ann Surg Oncol,2012,19(1):217-224.
  • 10Unitt E,Marshall A,Gelson W,et al.Tumor lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation[J].J Hepatology,2006,45(2):246-253.

二级参考文献30

  • 1Fogar P, Sperti C, Basso D, et al. Decreased total lymphocyte counts in pancreatic cancer:an index of adverse outcome. Pancreas, 2006,32 ( 1 ) : 22-28.
  • 2Chua W, Charles KA, Baracos VE, et al. Nentrnphil/ lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 2011,104 (8) : 1288-1295.
  • 3Shankaran V, lkeda H, Bruce AT, et al. IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 2001,410 (6832) : 1107-1111.
  • 4Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunot, 2002,3( 11 ) : 991-998.
  • 5Bui JD, Schreiber RD. Cancer immunosurveillance, immunoeditingand inflammation: independent or interdependent processes? Curr Opin Immunol, 2007,19(2) : 203-208.
  • 6Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002,420 ( 6917 ) : 860- 867.
  • 7Balkwill F, Mantovani A. Inflammation and cancer: back to Vircbow? Lancet, 2001,357 (9255) : 539-545.
  • 8Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature, 2008,454(7203) :436-444.
  • 9Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 2009,30(7) : 1073-1081.
  • 10Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011,144 ( 5 ) : 646-674.

共引文献39

同被引文献23

  • 1Bass D A, Parce J W, Dechatelet L R, et al.Flow cytometric studies of oxidative product formation by neutrophils: a graded response to mem-branestimulation[J].JImmunol, 1983, 130(4): 1910-1917.
  • 2Feng J F, Huang Y, Liu J S.Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma[J].Onco TargetsTher, 2013, 7(6): 1605-1612.
  • 3Hanaban D, Weinberg R A.Hallmarks of cancer: the next generation[J].Cell, 2011, 144(5): 646-674.
  • 4Kitayama J, Yasuda K, Kawai K, et al.Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal caneer[J].Radiat Oncol, 2010, 1(5): 47.
  • 5Yao Y, Yuan D, Liu H, et al.Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum- based chemotherapy[J].Cancer Immunol Immunother, 2013, 62(3): 471-479.
  • 6Azab B, Bhatt V R, Phookan J, et al.Usefulness of the neutrophil- to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients[J].Ann Surg Oncol, 2012, 19(1) : 217-224.
  • 7Kemal Y, Yucel I, Ekiz K, et al.Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis[J].Asian Pac J Cancer Prey, 2014, 15(6): 2651- 2654.
  • 8Feng J F, Huang Y, Chen Q X.The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma[J].Transl Oneol, 2014, 7(5): 632-637.
  • 9Feng J F, Huang Y, Chen Q X.A new inflammation index is useful for patients with esophageal squamous cell carcinoma[J].Onco Targets Ther, 2014, 30(7): 1811-1815.
  • 10Wang L, Lin Y, Long H, et al.Esophageal carcinosarcoma: a unique entity with better prognosis[J].Ann Surg Oncol, 2013, 20(3): 997-1004.

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部